Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.525
-0.205 (-4.33%)
Sep 10, 2026, 1:02 PM EDT - Market open
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $588.17 million as of September 10, 2026. Its market cap has increased by 15.00% in one year.
Market Cap
588.17M
Enterprise Value
352.63M
1-Year Change
15.00%
Ranking
Category
Stock Price
$4.53
ChartMarket Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $588.17M, a decrease of -73.98%. That is a compound annual growth rate of -23.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 600.52M | -7.00% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AdaptHealth | 825.80M |
| Varex Imaging | 779.32M |
| SS Innovations International | 655.26M |
| OrthoPediatrics | 580.16M |
| BrainsWay | 566.93M |
| Delcath Systems | 557.96M |
| Cerus | 511.87M |
| NeuroPace | 506.63M |